Centrum Medyczne ENEL-MED Income Statement

Financials in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	854.27	735.59	616.77	494.9	441.14
Revenue	854.27	735.59	616.77	494.9	441.14
Revenue Growth (YoY)	16.13%	19.27%	24.62%	12.19%	10.34%
Cost of Revenue	774.62	677.09	589.43	484.02	419
Gross Profit	79.64	58.51	27.34	10.88	22.14
Selling, General & Admin	58.32	35.54	32.9	37.12	23.82
Other Operating Expenses	-1.77	0.08	-9.07	-6.54	-3.73
Operating Expenses	56.55	35.62	23.84	30.58	20.09
Operating Income	23.09	22.89	3.5	-19.7	2.06
Interest Expense	-	-10.39	-10.16	-5.82	-5.33
Interest & Investment Income	1.31	1.24	1.64	2.46	1.64
Currency Exchange Gain (Loss)	2.2	3.12	14.61	-2.83	0.61
Other Non Operating Income (Expenses)	-10.21	-2.05	-0.02	-0.01	-0.01
EBT Excluding Unusual Items	16.39	14.82	9.57	-25.89	-1.03
Merger & Restructuring Charges	-	3.55	-	-	-
Gain (Loss) on Sale of Investments	-0.03	-0.01	-0.04	-0.77	-
Gain (Loss) on Sale of Assets	-0.77	-0.13	-3.72	-1.28	-0.1
Legal Settlements	-0.01	-0	-0.04	-	-0.02
Other Unusual Items	0.72	0.93	3.13	-	1.24
Pretax Income	16.31	19.14	8.89	-27.94	0.1
Income Tax Expense	3.42	4.54	0.97	-4.38	1.51
Earnings From Continuing Operations	12.89	14.61	7.93	-23.56	-1.41
Net Income	12.89	14.61	7.93	-23.56	-1.41
Net Income to Common	12.89	14.61	7.93	-23.56	-1.41
Net Income Growth	-11.75%	84.27%	-	-	-
Shares Outstanding (Basic)	28	28	28	28	24
Shares Outstanding (Diluted)	28	28	28	28	24
Shares Change (YoY)	-	-	-	17.55%	2.08%
EPS (Basic)	0.46	0.52	0.28	-0.83	-0.06
EPS (Diluted)	0.46	0.52	0.28	-0.83	-0.06
EPS Growth	-11.75%	84.49%	-	-	-
Free Cash Flow	31.96	58.34	55.17	-5.9	28.55
Free Cash Flow Per Share	1.13	2.06	1.95	-0.21	1.19
Gross Margin	9.32%	7.95%	4.43%	2.20%	5.02%
Operating Margin	2.70%	3.11%	0.57%	-3.98%	0.47%
Profit Margin	1.51%	1.99%	1.29%	-4.76%	-0.32%
Free Cash Flow Margin	3.74%	7.93%	8.95%	-1.19%	6.47%
EBITDA	58.05	51.14	29.63	5.53	24.79
EBITDA Margin	6.79%	6.95%	4.80%	1.12%	5.62%
D&A For EBITDA	34.95	28.25	26.13	25.22	22.73
EBIT	23.09	22.89	3.5	-19.7	2.06
EBIT Margin	2.70%	3.11%	0.57%	-3.98%	0.47%
Effective Tax Rate	20.95%	23.69%	10.86%	-	1568.75%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.